VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
44 hedge funds and large institutions have $51.4M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Holders
44
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.33M | |
| 2 | +$674K | |
| 3 | +$490K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$196K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$145K |
Top Sellers
| 1 | -$244K | |
| 2 | -$34.6K | |
| 3 | -$28.1K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$20.9K |
| 5 |
Barclays
London,
United Kingdom
|
-$20.5K |